title: Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases.
abstract: The value of biomarkers in the clinical management of lysosomal storage diseases is best illustrated by the present use of plasma chitotriosidase levels in the diagnosis and monitoring of Gaucher disease. The enzyme chitotriosidase is specifically produced and secreted by the pathological storage macrophages (Gaucher cells). Plasma chitotriosidase levels are elevated on average 1000-fold in symptomatic patients with Gaucher disease and reflect the body burden on storage cells. Changes in plasma chitotriosidase reflect changes in clinical symptoms. Monitoring of plasma chitotriosidase levels is nowadays commonly used in decision making regarding initiation and optimization of costly therapeutic interventions (enzyme replacement therapy or substrate reduction therapy). A novel substrate has been developed that further facilitates the measurement of chitotriosidase in plasma samples. Moreover, an alternative Gaucher-cell marker, CCL18, has been very recently identified and can also be employed to monitor the disease, particularly in those patients lacking chitotriosidase due to a genetic mutation. There is a need for comparable surrogate markers for other lysosomal storage diseases and the search for such molecules is an area of intense investigation.
  
  
  CONCLUSIONS
  The use of biomarkers can provide valuable insight into the molecular pathogenesis of LSDs, such as Gaucher disease and Fabry disease.
authors.affiliation: Departments of Biochemistry, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. j.m.aerts@amc.uva.nl
authors.forename: J M F G
authors.initials: JM
authors.lastname: Aerts
authors.forename: C E M
authors.initials: CE
authors.lastname: Hollak
authors.forename: M
authors.initials: M
authors.lastname: van Breemen
authors.forename: M
authors.initials: M
authors.lastname: Maas
authors.forename: J E M
authors.initials: JE
authors.lastname: Groener
authors.forename: R G
authors.initials: RG
authors.lastname: Boot
mesh_terms: D015415:Biomarkers; D019742:Chemokines, CC / Q000235:genetics*; D005776:Gaucher Disease / Q000201:enzymology / Q000235:genetics / Q000503:physiopathology; D006596:Hexosaminidases / Q000378:metabolism*; D006801:Humans; D016464:Lysosomal Storage Diseases / Q000175:diagnosis / Q000503:physiopathology
chemical_list: D015415:Biomarkers; C111792:CCL18 protein, human; D019742:Chemokines, CC; D006596:Hexosaminidases; C086400:chitotriosidase